SEC Filing Madrigal Pharmaceuticals.
By A Mystery Man Writer
Conshohocken-based Madrigal Pharmceuticals plans a $500M stock sale - Philadelphia Business Journal
Madrigal Pharmaceuticals: A Deeper Look At A Looming NASH Play (NASDAQ:MDGL)
Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Shares Acquired by Charles Schwab Investment Management Inc. - Defense World
SEC Filing NeuroBo Pharmaceuticals, Inc.
SEC Filing Madrigal Pharmaceuticals.
EDGAR Filing Documents for 0001193125-24-068170
SEC Filing – Axcella Therapeutics
SEC Filing Madrigal Pharmaceuticals.
MDGL / Madrigal Pharmaceuticals, Inc. - Put/Call Ratio, Options Sentiment, Unusual Options Activity
